mdRNA Report issue

For profit Phase 2
Founded: Bothell WA United States (1983)
Status: Acquired by Marina Biotech (2010) → now Adhera (2018)

Organization Overview

First Clinical Trial
2007
NCT00537420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree